EMAIL THIS PAGE TO A FRIEND

Scientific reports

Octanoylation of early intermediates of mycobacterial methylglucose lipopolysaccharides.


PMID 26324178

Abstract

Mycobacteria synthesize unique intracellular methylglucose lipopolysaccharides (MGLP) proposed to modulate fatty acid metabolism. In addition to the partial esterification of glucose or methylglucose units with short-chain fatty acids, octanoate was invariably detected on the MGLP reducing end. We have identified a novel sugar octanoyltransferase (OctT) that efficiently transfers octanoate to glucosylglycerate (GG) and diglucosylglycerate (DGG), the earliest intermediates in MGLP biosynthesis. Enzymatic studies, synthetic chemistry, NMR spectroscopy and mass spectrometry approaches suggest that, in contrast to the prevailing consensus, octanoate is not esterified to the primary hydroxyl group of glycerate but instead to the C6 OH of the second glucose in DGG. These observations raise important new questions about the MGLP reducing end architecture and about subsequent biosynthetic steps. Functional characterization of this unique octanoyltransferase, whose gene has been proposed to be essential for M. tuberculosis growth, adds new insights into a vital mycobacterial pathway, which may inspire new drug discovery strategies.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

G0750
D-(+)-Galactose, ≥99%
C6H12O6
G0625
D-(+)-Galactose, ≥98%
C6H12O6
G6404
D-(+)-Galactose, BioXtra, pH 5.0-7.0 (20 °C, 1 M in H2O), ≥99%
C6H12O6
G5388
D-(+)-Galactose, powder, anhydrous, BioReagent, suitable for cell culture, suitable for insect cell culture
C6H12O6
15522
D-(+)-Galactose, meets analytical specification of Ph. Eur., BP
C6H12O6
ARK2181
D-(+)-Mannose, PharmaGrade, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production
C6H12O6
M2069
D-(+)-Mannose, from wood, ≥99%
C6H12O6
M8574
D-(+)-Mannose, synthetic, ≥99%
C6H12O6
M6020
D-(+)-Mannose, powder, BioReagent, suitable for cell culture
C6H12O6
63579
D-(+)-Mannose, BioUltra, ≥99.5% (sum of enantiomers, HPLC)
C6H12O6
M4625
D-(+)-Mannose
C6H12O6
ARK2176
Galactose, plant-derived, PharmaGrade, USP/NF, Ph Eur, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.
C6H12O6
I7253
Isomaltose, ~98% (TLC)
C12H22O11
M7753
Maltoheptaose, ≥60% (HPLC)
C42H72O36
M9153
Maltohexaose, ≥65% (HPLC)
C36H62O31
M8128
Maltopentaose, ≥95%
C30H52O26
M8378
Maltotriose, ≥90% (HPLC)
C18H32O16
84010
NBT Vials, for in vitro diagnostic use
C40H30Cl2N10O6
N6876
Nitrotetrazolium Blue chloride, ~98% (TLC)
C40H30Cl2N10O6
N6639
Nitrotetrazolium Blue chloride, powder, electrophoresis grade
C40H30Cl2N10O6
74032
Nitrotetrazolium Blue chloride, ≥98.0% (calc. based on dry substance, T)
C40H30Cl2N10O6
W279900
Octanoic acid, ≥98%, FG
C8H16O2
W279927
Octanoic acid, natural, ≥98%, FG
C8H16O2
O3907
Octanoic acid, ≥98%
C8H16O2
C2875
Octanoic acid, ≥99%
C8H16O2
84097
Sucrose, BioUltra, for molecular biology, ≥99.5% (HPLC)
C12H22O11
S9378
Sucrose, ≥99.5% (GC)
C12H22O11
S0389
Sucrose, for molecular biology, ≥99.5% (GC)
C12H22O11
S1888
Sucrose, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99.5% (GC)
C12H22O11
S8501
Sucrose, ≥99.5%
C12H22O11